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suppression of apoptosis (Franke et al., 1997), reorgani-
zation of the actin cytoskeleton (Rodriguez-Viciana et
al., 1997), cardiac myocyte growth (Shioi et al., 2000),
glycogen synthase stimulation by insulin (reviewed in
Shepherd et al., 1998), TNFa-mediated neutrophil prim-
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ing and superoxide generation (Condliffe et al., 1998),Hills Road
and leukocyte migration and adhesion to endothelialCambridge CB2 2QH
cells (reviewed in Wymann et al., 2000).United Kingdom
There are two types of class I PI3Ks. Class IA consists†The Babraham Institute
of p110a, b, and d catalytic subunits that associate withBabraham
an SH2 domain–containing subunit (p85a and spliceCambridge CB2 4AT
variants of it, p85b or p55g) that is indispensable forUnited Kingdom
activation by phosphotyrosine-containing proteins (Car-‡National Institute for Medical Research
penter et al., 1993). Consequently, the class IA PI3Ks areThe Ridgeway
typically activated by receptors that regulate tyrosineMill Hill
kinases. Class IB contains only one member, PI3Kg. ThisLondon NW7 1AA
enzyme is regulated by G protein–coupled receptors viaUnited Kingdom
association with bg subunits of heterotrimeric G pro-
teins (Stoyanov et al., 1995). A p101 regulatory subunit
that tightly binds p110g is critical for Gbg-activatedSummary
PtdIns(3,4,5)P3 production (Stephens et al., 1997; Krug-
mann et al., 1999; Maier et al., 1999). All class I PI3KsRas activation of phosphoinositide 3-kinase (PI3K) is
have a domain that is similar to a Ras binding domainimportant for survival of transformed cells. We find
(RBD) present in other proteins that are regulated bythat PI3Kg is strongly and directly activated by H-Ras
the GTPase Ras. Furthermore, all class I PI3Ks bind RasG12V in vivo or by GTPgS-loaded H-Ras in vitro. We
in a GTP-dependent manner (Rodriguez-Viciana et al.,have determined a crystal structure of a PI3Kg/
1994; Rubio et al., 1997; Vanhaesebroeck et al., 1997;Ras·GMPPNP complex. A critical loop in the Ras bind-
Deora et al., 1998).ing domain positions Ras so that it uses its switch I
The Ras family of membrane-localized GTPasesand switch II regions to bind PI3Kg. Mutagenesis
transduces a variety of signals in eukaryotic cells (Lowyshows that interactions with both regions are essential
and Willumsen, 1993; Shields et al., 2000). The exchangefor binding PI3Kg. Ras also forms a direct contact with
of GDP for GTP causes two regions of Ras, known asthe PI3Kg catalytic domain. These unique Ras/PI3Kg
switch I (residues 32–40) and switch II (residues 60–76),interactions are likely to be shared by PI3Ka. The com-
to change conformation (Pai et al., 1989; Milburn et al.,plex with Ras shows a change in the PI3K conforma-
1990). This GTP-induced conformational change allowstion that may represent an allosteric component of
Ras to bind and activate multiple downstream effectors,Ras activation.
which can cooperate to produce the diverse phenotypes
characteristic of Ras transformation (White et al., 1995;Introduction
Marshall, 1996) or function independently in activating
survival pathways (Xue et al., 2000). Most Ras-depen-
The phosphoinositide 3-kinases are a family of ubiqui-
dent signaling is mediated by three downstream ef-
tous multidomain signaling proteins that phosphorylate
fectors: the protein kinase Raf, the exchange factor
the 3-hydroxyl of phosphoinositides. Mammalian PI3Ks RalGDS, and PI3K (reviewed in Wittinghofer and Herr-
are divided into three classes based on their structure mann, 1995; Feig et al., 1996; Rodriguez-Viciana et al.,
and substrate specificity (Domin and Waterfield, 1997). 1996a).
Class I enzymes are acutely activated by a variety of Although all class I PI3Ks bind Ras, only PI3Ka has
cell-surface receptors, and are responsible for synthesis been shown to be directly stimulated by Ras·GTP (Rodri-
of intracellular phosphatidylinositol (3,4,5)-trisphosphate guez-Viciana et al., 1994, 1996b). Ras-induced activation
(PtdIns(3,4,5)P3). Thus, stimulation of many cells results in is synergistic with p85-mediated stimulation of PI3Ka by
the PI3K-dependent accumulation of PtdIns(3,4,5)P3 in the phosphotyrosine peptides. Direct Ras activation of PI3Ka
inner leaflet of the plasma membrane. This usually tran- stimulates actin rearrangement and inhibits programmed
sient production of PtdIns(3,4,5)P3 initiates a multitude cell death upon detachment from the extracellular matrix
of further downstream signals by causing membrane (anoikis) (Khwaja et al., 1997; Rodriguez-Viciana et al.,
recruitment of proteins that specifically bind PtdIns 1997). Other consequences of Ras activation of PI3Ks
(3,4,5)P3. Typically, this results in a colocalization of en- include cell transformation (Gire et al., 2000), T cell adhe-
zymes and substrates that fires further signaling activity. sion and migration (Tanaka et al., 1999), and blocking
Cellular processes in which PI3Ks are essential include of apoptosis induced by c-Myc (Kauffmann-Zeh et al.,
1997) or by NGF deprivation (Xue et al., 2000).
A recent crystal structure of PI3Kg (Walker et al., 1999)§ To whom correspondence should be addressed (e-mail: rlw@mrc-
lmb.cam.ac.uk). showed that the Ras binding domain of the kinase packs
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Figure 1. Direct Activation of PI3Kg by H-Ras
(A) In vitro activation of PI3Kg by posttranslationally modified, EE-tagged H-Ras·GTPgS using pig neutrophil membranes as a substrate. 32P-labeled
phosphoinositides were extracted, deacylated, separated by HPLC, and measured by scintillation counting. The data for [32P]-PtdIns(3)P,
[32P]-PtdIns(3,4)P2, and [32P]-PtdIns(3,4,5)P3 are shown. Descriptions of the DASAA and DEDAA mutants are in the Experimental Procedures.
The data are representative of three experiments and were normalized by the amount of PI3Kg used in the assay.
(B) In vivo activation of myc-tagged p110g and the myc-p110g / EE-tagged p101 heterodimer by H-Ras G12V, and coactivation of myc-p110g/
EE-p101 heterodimer with Gbg and H-Ras G12V. The error bars represent the range of two experiments.
(C) In vivo activation of untagged wild-type and DASAA mutant p110g by H-Ras G12V in the absence of p101. COS-7 cells were transfected
with expression vectors containing the indicated genes. The levels of 32P-labeled phosphoinositides were normalized to 2 3 105 counts of
PtdIns(4)P. The error bars represent the range of two experiments. A Western blot of the cell lysates with an anti-p110g antibody shows
similar expression of p110g. A Western blot with anti-Ras antibody shows similar expression of Ras (not shown).
against the catalytic domain. Here, we show that Ras with PI3Kg provides a glimpse into the structural ramifi-
cations of Ras binding in the context of a full-lengthforms a transient complex with PI3Kg and activates it
in vitro and in vivo. To characterize the PI3K interaction effector enzyme.
with Ras, we have trapped a Ras·PI3Kg complex and
determined its structure by X-ray crystallography. This Results and Discussion
Ras complex with PI3Kg shows interactions that are
unique to PI3K, and is probably also a good model for Ras·GTP Directly Activates PI3Kg
To determine the consequences of Ras binding tothe interaction of PI3Ka with Ras. The conformational
changes that take place in PI3Kg upon Ras binding are PI3Kg, we investigated the effect of full-length, lipid
modified, GDP- or GTPgS-loaded H-Ras on PI3Kg activ-consistent with the possibility that an allosteric mecha-
nism, in addition to membrane recruitment, may be im- ity in vitro, using a plasma-membrane enriched mem-
brane preparation from neutrophils. Our results indicateportant in the activation of PI3K. Our complex of Ras
Activation of PI3Kg by Ras
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Figure 2. Binding of PI3Kg to Ras
(A) Solution binding of PI3Kg RBD mutants (144–1102 constructs) to N-Ras·mant-GMPPNP as measured by fluorescence anisotropy. Titration
of some mutants was limited by reduced mutant solubility. All error bars represent the standard deviation of at least two measurements. Kd
values are listed in the adjacent table. For mutants with no detectable binding, the Kd is listed as .50.
(B) Transient kinetic measurements of the association and dissociation rates of the PI3Kg 144–1102 construct to N-Ras·mant-GMPPNP. The
pseudo first-order association rates were determined at the PI3Kg concentrations shown.
(C) Transient and steady-state measurements of mant-ATP and mant-ADP binding to PI3K. All data were collected by fluorescence energy
transfer from tryptophan to mant. The Kd values were determined by equilibrium titrations.
(D) Steady-state binding of PI3Kg (144–1102 construct) to full-length, unprocessed H-Ras mutants. The data were obtained as in Figure 2A.
For comparison, PI3Kg binding to H-Ras G12V·mant-GDP is shown.
that H-Ras·GTPgS causes an approximately 8- to 20- for Ras binding were mutated. These multiple mutants
(DASAA and DEDAA, see Experimental Procedures)fold increase in the activity of the p110g catalytic subunit
(Figure 1A). This activation is strictly dependent on have the same basal activity as the wild-type enzyme
in vitro, but are not activated by H-Ras·GTPgS (FigureRas·GTPgS, and is at least as great as the reported
stimulation of the p110a/p85 heterodimer by Ras (Rodri- 1A). These results demonstrate that H-Ras directly acti-
vates PI3Kg.guez-Viciana et al., 1996b). Based on our structure of a
complex of PI3Kg with Ras (see below), we constructed Previously, it was reported that PI3Kg is not stimulated
by Ras in COS-7 cells (Rubio et al., 1997). Because oftwo p110g variants in which several residues essential
Cell
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Figure 3. Structure of a Ras·PI3Kg Complex
(A) Diagram of the PI3Kg·Ras interface. Also shown are the residues that hold the 255–267 loop in place. The RBD is colored purple, the Ras
is orange, and the catalytic domain is yellow. Putative hydrogen bonds are indicated by dashed lines, and possible salt bridges by dotted
lines. PI3Kg residues that can be mutated to eliminate or attenuate binding are colored red or blue, respectively. Ellipses indicate residues
that were mutated to enhance binding. The V223K tighter binding mutant is shown hydrogen bonding to Ras Glu37.
(B) A closer view of the interface between the RBD (purple) and Ras (orange). The switch I and switch II regions of Ras are colored pale and
dark blue, respectively. Boxes around residue labels denote mutations that abolish binding, and ellipses indicate mutations that enhance
binding. The 255–267 loop that becomes ordered on binding is colored dark green. The GMPPNP and Mg21 in Ras are rendered in gray.
(C) Molecular surface of the Ras·PI3Kg complex. The Ras (orange) and four domains of the PI3Kg, comprising the RBD (purple), C2 domain
(cyan), helical domain (green), and N- and C-terminal lobes of the catalytic domain (red and yellow) are shown. The N-terminal linker is rendered
in white. A schematic of PI3Kg domain organization is also shown.
(D) Ribbon diagram of the Ras·PI3Kg complex. The color scheme is the same as the previous panel. The location of the g phosphate of the
ATP·PI3Kg structure is marked with a large gray sphere. This location roughly corresponds to the phosphoinositide headgroup binding site.
Activation of PI3Kg by Ras
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Figure 4. A Comparison of the Ras or Rap1A Orientations in Complexes with the RBDs from PI3K, Raf, and RalGDS
The RBDs were automatically superimposed using the “brute” option of LSQMAN (Kleywegt, 1999). The molecules are colored as in Figure
3. To help visualize the different orientations of bound Ras, lines are traced from the centroid of the RBD through the Ca of Thr232 in PI3Kg
(or its equivalent in other RBDs), then to the centroid of Ras bound to PI3Kg (cyan sphere and solid line), Raf (red sphere and dotted line),
and RalGDS (yellow sphere and dashed line). (A) The PI3Kg RBD·Ras complex. (B) The Rap1A·RafRBD complex (PDB:1gua). (C) The Ras·RalGDS
RBD complex (PDB:1lfd). The orientation of the Ras in this complex is more similar to that of Ras in the PI3Kg complex than that of Rap1A
in the RafRBD complex.
this apparent inconsistency with the in vitro activation H-Ras and p110g. The discrepancy between our results
and those previously published may be due to differ-that we observed, we reexamined this issue of in vivo
activation. We transfected COS-7 cells with various ences in the constructs used for the transfections.
combinations of expression vectors encoding H-Ras
G12V, full-length p110g, p101, Gb1, and Gg2. These data PI3Kg Forms a Transient Complex
with Ras·mant-GMPPNPindicate that p110g alone, and the p101/p110g hetero-
dimer, are activated 23- and 20-fold, respectively, by We characterized the solution binding of PI3Kg to Ras
by observing changes in the fluorescence anisotropyH-Ras G12V (Figure 1B). In the presence of Gbg, H-Ras
further stimulates both p110g and p101/p110g by 22- of full-length, unmodified N-Ras·mant-GMPPNP (mant,
29-(or-39)-O-(N-methylanthraniloyl)). The Kd for wild-typeand 8-fold above the level produced by Gbg stimulation
(Figure 1B). As in the in vitro experiments, the DASAA PI3Kg and N-Ras·mant-GMPPNP is 2.8 6 0.4 mM. The
Kd for wild-type H-Ras (3.2 6 0.5 mM) is nearly identicalRas binding– deficient p110g mutant was insensitive to
H-Ras G12V, although it was comparably expressed in to the Kd for N-Ras. This dissociation constant is higher
than the 160 nM Kd for the Ras·Raf RBD complex (Herr-COS-7 cells (Figure 1C). The effect of H-Ras G12V on
p110g activity in COS-7 cells was completely insensitive mann et al., 1995; Sydor et al., 1998) and the 1 mM Kd for
the Ras·RalGDS RBD complex (Herrmann et al., 1996). Itto pretreatment with U0126, a potent ERK pathway in-
hibitor (the inhibitor resulted in a 92% decrease in MAPK is also approximately 10-fold higher than the previously
published dissociation constant for PI3Kg and Rasactivity; data not shown). These results indicate that
stimulation of p110g activity by H-Ras G12V in COS-7 (Rubio et al., 1999). The discrepancy between our results
and those reported previously for p110g may be duecells is the consequence of a direct interaction between
Cell
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Figure 5. Conformational Changes in the Ras·PI3Kg Structure
(A) The structure of PI3Kg bound to ATP is traced through the Ca’s as a black dotted line. The structure of the Ras·PI3Kg complex is traced
in a solid line and the domains are colored as in Figure 3. A gray sphere marks the location of the g-phosphate of ATP in the structure of the
enzyme in the absence of Ras. This would presumably be adjacent to the phospholipid headgroup binding site.
(B) A view of the conformational changes in the catalytic domain. The free and Ras-bound PI3Kg catalytic domains were superimposed using
their N-terminal lobes.
to differences in the constructs and methods used to PtdIns(3,4,5)P3 that have been reported for PI3Kg (0.1
s21; Maier et al., 1999) or for PI3Ka (0.8 s21; Carpenter etdetermine the dissociation constants. The previously
published work used pull-down assays with an immobi- al., 1990). As with the Ras·Raf complex, the “activating”
interaction of PI3Kg with Ras is limited by the dissocia-lized GST-PI3Kg construct.
Although the solution Kd for the PI3Kg·Ras complex tion of the Ras·effector complex and not by the catalytic
cycle of the effector enzyme. The transience of the com-is high, it would be sufficient for interaction of the two
proteins on lipid membranes. A similar situation is ap- plex ensures that PI3Kg is not constitutively activated.
parent for other signaling complexes that are active at
membrane surfaces. For example, the estimated affinity Structure of a Ras·PI3Kg Complex
Initial crystallization trials of Ras·PI3Kg were unsuccess-of phospholipase Cb2 (PLCb2) for the Gbg subunits in
the bulk phase is about 3 mM (Runnels and Scarlata, ful, perhaps because of the transience of the complex.
Therefore, we constructed two tighter binding PI3K mu-1998), yet Gbg is one of the principal activators of PLCb2
in cells. Because PLCb2 and Gbg subunits have high tants, V223K and E267K, for cocrystallization with Ras.
The Kds for Ras·GMPPNP of these and other mutantsaffinities for membrane, these signaling components be-
come concentrated on membrane surfaces. Conse- discussed below are shown in Figure 2A. Neither the
wild-type protein, the pseudo wild type (V326A, see Ex-quently, even fairly weak interactions lead to lateral as-
sociation on the membrane. PI3Ka and PI3Kg (Barnett perimental Procedures), nor the V223K mutant exhibit
detectable binding to N-Ras·GDP, consistent with theet al., 1995 and S. Krugmann and L. S., unpublished
data) have been shown to bind to phosphoinositide- role of PI3Kg as an effector (data not shown). With the
V223K mutant, we obtained crystals of the Ras·PI3Kgcontaining membranes even in the absence of any other
protein components. Therefore, the bulk affinities that complex.
The overall organization of the PI3Kg catalytic subunitwe measure for soluble Ras may translate into a signifi-
cant interaction with membrane-localized Ras. This is (Walker et al., 1999), which contains a Ras binding do-
main (RBD), a C2 domain, a helical domain, and a cata-consistent with our observation that the K255A mutant
is activated by H-Ras G12V to half of the extent of the lytic domain, is preserved in the structure of the complex
(Figure 3). PI3Kg, Raf, and RalGDS interact with manywild-type p110g in COS-7 cells (data not shown) despite
having an affinity for soluble N-Ras·mant-GMPPNP that of the same switch I residues of Ras. However, a unique
feature of the PI3Kg·Ras complex is that the switch IIwas so weak that it could not be measured by fluores-
cence anisotropy. region is also involved. Interactions with Ras switch II
residues have previously only been observed in com-Dynamic studies of PI3Kg and N-Ras indicate both
rapid association and dissociation of the two proteins plexes of Ras with its upstream regulators, GTPase acti-
vating proteins (Scheffzek et al., 1997) and guanine nu-(Figure 2B). While the dissociation rate of the complex
is similar to that of Ras·Raf RBD, the association rate cleotide exchange factors (Boriack-Sjodin et al., 1998).
One prominent feature of the interaction with Ras isof PI3Kg·Ras is an order of magnitude slower (Sydor et
al., 1998). The dissociation rate constant of the Ras·PI3K the ordering of a loop, residues 255 to 267, in the RBD
(Figure 3B), that is not visible in the free PI3Kg structure,complex (.18 s21) is at least an order of magnitude
higher than the maximal catalytic turnover rates for but is clearly defined in the electron density of the com-
Activation of PI3Kg by Ras
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plex. This loop prevents Ras from binding to the PI3Kg permits formation of an additional hydrogen bond be-
tween the RBD Lys223 and Ras Glu37.RBD in the same orientation as Ras bound to Raf and
RalGDS. Consequently, Ras establishes novel switch II
contacts with the PI3Kg RBD and catalytic domain. Ras Makes Essential Interactions with PI3K
Using Its Switch II Region
Unlike any other effectors downstream of Ras, PI3Kg
Ras Binding Induces Ordering of a Critical Loop
makes critical interactions with the switch II region. Al-
at the RBD·Ras Interface
though early structural studies of Ras showed that both
The entropic cost of locking the PI3Kg 255–267 loop into
switch I and switch II regions of Ras changed conforma-
a single conformation might be offset by interactions
tion upon GTP binding, and transforming mutants of
formed between residues in the loop, and between the
Ras involving both of these regions have been reported,
loop and the rest of the RBD. Eliminating these interac-
the structures of other effector RBDs in complexes with
tions or providing additional ones would affect the sta-
Ras showed only switch I interactions. In the PI3Kg·Ras
bility of the loop, and concomitantly decrease or in-
complex, we observe extensive switch II contacts that
crease the affinity of Ras for the kinase. In support of
are probably the consequence of the unique orientation
this hypothesis, the PI3Kg mutants R226A, K256A, and
of Ras relative to the RBD of PI3Kg. We have generated
D260A all eliminate hydrogen bonds or salt bridges that
two mutants, F221S and K234A, involving residues that
stabilize the 255–267 loop (Figure 3A), and reduce bind-
make switch II contacts. F221S eliminates hydrophobic
ing up to 10-fold (Figure 2). The side chain of another
interactions between PI3Kg Phe221 and Tyr64 in switch
attenuating mutant, Lys254, points away from the Ras.
II. Mutation of Lys234 to Ala probably increases the
Nevertheless, mutation of this residue to Ala greatly
Kd by eliminating hydrogen bonds to switch II residueslowers the affinity of PI3Kg for Ras, possibly by permit-
Glu63 and Tyr64 (Figure 3A). These mutants confirm
ting more flexibility in the turn containing the critical
the essential role of Ras Switch II in binding PI3Kg. In
residues Lys255 and Lys256. The complex-stabilizing
addition, the Y64G Ras mutation abolishes binding of
E267K mutant would permit the formation of an addi-
a class IA PI3K (Moodie et al., 1995), suggesting that
tional hydrogen bond from the mutant Lys267 to the
interaction with the Ras switch II is probably a general
backbone amide oxygen of Phe249, which could further
characteristic of PI3K·Ras complexes.
stabilize the 255–267 loop and helix Ra1. Apparently,
this also offsets any destabilization that arises from plac-
The PI3K Catalytic Domain Makes Direct
ing Lys267 and Lys255 fairly near each other on the
Interactions with Switch II of Ras
surface of the protein.
Ras directly contacts the C-terminal lobe of the PI3Kg
catalytic domain. Arg73 in the switch II region of Ras is
near Glu919 in the turn between helices ka5 and ka6. TheThe Switch I Region of Ras Forms Typical Effector
E919A mutant shows wild-type affinity for Ras; however,Interactions with PI3K
the E919K mutation greatly increases affinity for RasAt the interface between Ras and the PI3Kg RBD, strand
(Figure 2A), presumably by forming a new salt-link be-b2 of Ras is aligned with PI3Kg strand Rb2 (Figure 3B).
tween the catalytic domain and Asp69 in switch II ofThis produces a continuous antiparallel b sheet between
Ras. This suggests that the close approach of Ras tothe Ras and the RBD. The interaction is common to
the catalytic domain that we see in the structure is notstructures of Rap1A and Ras in complexes with Raf-
simply an artifact of crystal packing. This direct contactRBD and RalGDS-RBD, respectively (Nassar et al., 1995;
between the PI3K catalytic domain and Ras may contrib-Huang et al., 1998; Vetter et al., 1999). Most of the inter-
ute to the conformational change in the phospholipidactions between Ras and PI3Kg are either hydrogen
binding site of PI3Kg (see below).bonds or salt bridges (Figure 3A), in agreement with
the observation that the affinity of the two proteins is
inversely related to the ionic strength of the buffer (data Ras Binds to RBDs in Effector-Specific
Orientationsnot shown). The area of the interface between the PI3Kg
RBD and Ras (1308 A˚2) is similar to the surface areas Two structures of isolated RBD complexes with Ras or
the Ras-like protein Rap1A have been previously solved.of the Raf RBD (1333 A˚2) and RalGDS RBD (1331 A˚2)
interfaces. In Figure 4, the Raf RBD·Rap1A complex (Nassar et al.,
1995) and the RalGDS RBD·Ras complex (Huang et al.,The effects of several PI3Kg mutations that we made
in the RBD·Ras interface are consistent with their appar- 1998) are compared with the PI3Kg·Ras complex.
All three Ras·RBD complexes use a similar generalent roles in forming switch I contacts. The T232D,
K251A/E, and K255A mutations all eliminate binding by mode of Ras-effector interaction, in which a b sheet in
the Ras and a b sheet in the RBD are aligned to form aremoving hydrogen bond donors or acceptors from the
Ras switch I·PI3Kg interface, and in the case of the single b sheet connecting the two proteins. Contacts
between the switch I region of Ras and the RBD stabilizeT232D and K251E mutations, by putting negatively
charged PI3Kg side chains into proximity with negatively the interaction and ensure its dependence on Ras-GTP.
Despite the common mode of the Ras·RBD interac-charged side chains in Ras (Figure 3A). K251E is the
equivalent of the K227E mutant in PI3Ka, which also tion, Ras discriminates among its effectors by rotating
with respect to the RBD of a given effector. Ras boundeliminates Ras binding (Rodriguez-Viciana et al., 1996b;
Bondeva et al., 1998). The mechanism of the tighter to PI3Kg is rotated by 358 relative to the centroid of
Rap1A bound to the Raf RBD, and by 178 relative to Rasbinding V223K mutant can be explained in terms of inter-
action with the switch I region, because this mutation bound to the RalGDS RBD (Figure 4A). In PI3Kg, the
Cell
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Figure 6. A Putative Model of the Ras·PI3Kg Complex at a Membrane Surface
All regions not visible in the structure are drawn as dashed lines. Lys973 marks the substrate binding loop. The 20 residue C-terminal tail of
Ras was arbitrarily modeled to illustrate that this peptide could easily span the gap between the RBD-bound Ras and the putative membrane
surface. The location of the farnesyl group is indicated schematically. Potential membrane-interacting residues at the tips of the catalytic
domain loops are labeled.
length of helix Ra1 and the size of the subsequent loop Structural Insights into Signaling
Pathway–Specific Ras Mutations(255–267) cause a significant rotation of Ras relative to
the PI3Kg RBD and results in switch II interactions, for Five Ras mutants have been defined that differentially
affect Raf, RalGDS, and PI3Ka signaling pathways.which there are no equivalents in the other Ras effector
RBDs. The 255–267 loop appears longer in PI3Kg and These mutants, T35S, E37G, D38E, Y40C, and Y64G,
have served as useful tools for unraveling networks ofa than in PI3Ks b and d. This is in agreement with the
observation that PI3Kd appears to differ from PI3Ka in signal transduction pathways (White et al., 1995; Rodri-
guez-Viciana et al., 1997). The selective activation dis-its interaction with Ras (Kinashi et al., 2000).
Activation of PI3Kg by Ras
939
played by the switch I mutants (T35S, E37G, D38E, and Lys234. In contrast, neither Raf nor RalGDS RBDs con-
tact any residues in switch II (Nassar et al., 1995; VetterY40C) appears to be due to subtle differences in the
network of interactions that the switch I region makes et al., 1999).
in the three Ras/effector complexes. For the switch II
mutant (Y64G), PI3K activation is probably selectively Conformational Change in the Ras·PI3Kg Complex
abrogated simply because PI3K forms a switch II con- In addition to the induced fit of residues 255–267 at
tact whereas the other effectors do not (Vetter et al., the interface with Ras, the structure of the Ras·PI3Kg
1999). complex demonstrates that there are other more wide-
E37G is a Ras mutant that activates RalGDS but not spread conformational changes relative to the structure
Raf. Although this mutant does not bind to or activate of the enzyme in the absence of Ras. Most of the confor-
PI3Ka, it was recently shown to activate PI3Kd (Kinashi mational change, as illustrated in Figure 5A, occurs in
et al., 2000). We find that, as with PI3Kd, PI3Kg binds the C2 domain and the C-terminal lobe of the catalytic
Ras E37G similarly to wild-type Ras (Figure 2D). Glu37 domain. When the structure of the free PI3Kg and the
of Ras forms only a weak ionic interaction with RalGDS, structure of the complex are superimposed on the Ras
while it forms two hydrogen bonds with the guanidinium binding domain, the RMS deviation of the Ca atoms for
group of Arg59 in Raf. Although we see a salt link be- the C2 domain is 1.7 A˚. The RMS deviation of the Ca
tween PI3Kg Lys223 and Ras Glu37 in the structure of atoms for the C-terminal lobe of the catalytic domain is
the V223K mutant, this interaction would not be possible 1.9 A˚. The maximum deviation is 4.6 A˚ at the Ca of
with the wild-type PI3Kg, consistent with the unimpaired Pro916, which is located between helices ka5 and ka6
binding of PI3Kg to the Ras E37G mutant. The residue in the C-terminal lobe of the catalytic domain. These
in PI3Ka at the position equivalent to PI3Kg Val223 is values are well outside the cross-validated sA estimate
also a Val (Val193). This suggests that in PI3Ka another of the error of the atom positions, which is 0.7 A˚ (based
residue in the vicinity of Val193 interacts with Ras Glu37. on the free set of reflections). Neither the N-terminal
One candidate for such a residue is Lys206 of PI3Ka. lobe of the catalytic domain nor the overall RBD show
Neither PI3Kg nor PI3Kd have a basic residue at the significant conformational change. The deviation of the
equivalent position. helical domain in the structure of the complex from the
D38E and T35S are Ras mutants that selectively acti- free PI3Kg structure is probably due to proteolysis in
vate the Raf signaling pathway. PI3Ka (Rodriguez-Vici- this domain (see Experimental Procedures).
ana et al., 1997), PI3Kd (Kinashi et al., 2000), and PI3Kg In PI3Kg, the ATP binding site is located between the
(Figure 2D) all show considerably reduced binding to N- and C- terminal lobes of the catalytic domain. As in
these mutants. It is not clear from the structure why the protein kinases (Zhou and Adams, 1997), mant-ADP
the T35S mutant eliminates PI3K binding. Asp38 makes release is slower than mant-ATP release (Figure 2C). In
important contacts with the RBDs of all three effectors the Ras·PI3Kg complex, helix ka6 in the C-terminal lobe
and D38A prevents Ras activation of these pathways. of the catalytic domain is pulled toward the Ras, and
the entire ATP binding site moves with it, but apart fromThe D38E mutation conserves the negative charge, but
Asp964, none of the residues in the ATP binding siteit introduces a larger residue into the intricate interface.
significantly change conformation. Consistent with thisThis is only tolerated in Raf because Thr68 of Raf leaves
observation, neither the dissociation rate constants norsufficient space in the vicinity of the side chain of Ras
the Kd for either mant-ATP or mant-ADP change in theresidue 38. In PI3Kg, the bulky Gln231 occupies the
presence of Ras (data not shown).space analogous to Thr68 of Raf and prevents Ras D38E
Unlike the ATP binding pocket, the putative phospho-binding, while in RalGDS, this space is filled by Lys32.
inositide headgroup binding site appears to substan-In PI3Ka and PI3Kd, a bulky residue (Tyr207 and Phe203,
tially change conformation upon Ras binding, as therespectively) also occupies this space.
C-terminal lobe of the catalytic domain pivots aroundOne Ras mutation that has been used widely to selec-
the N-terminal lobe (Figure 5B). Unfortunately, we havetively activate PI3Ka is the Y40C mutation. Surprisingly,
been unable to grow crystals in the presence of a phos-this mutation eliminates binding to PI3Kd (Kinashi et al.,
pholipid headgroup analog, so we cannot be sure of2000) and attenuates binding to PI3Kg (Figure 2D). Tyr40
the detailed structural changes relevant to headgroupforms a putative hydrogen bond to Gln231. Mutation of
binding. The backbones of helices ka9, ka10, and ka11,Tyr40 to Cys probably eliminates this potential hydrogen
as well as kb10 and ka7, which hold the activation loopbond and reduces PI3Kg binding. Since Gln231 is not
in place, all substantially change position. Any allostericconserved in PI3Ka, the hydrogen bond between Ras
mechanism of activation would probably involve aTyr40 may not be present, and the Y40C mutation would
change in the affinity of phospholipid substrate binding,not affect binding. In complexes with Raf and RalGDS,
or perhaps an increase in the kcat of the enzyme.the role of Ras Tyr40 appears to be to restrict the motion
Although we cannot rule out proteolysis of the enzymeof a nearby basic residue in the RBD (Arg89 in Raf and
or crystal packing as the cause of the conformationalLys32 in RalGDS), which forms a critical salt bridge with
changes that we see, the consistency of the biochemicalRas Asp38.
and structural data suggests that this structure demon-The Ras mutant Y64G selectively inhibits PI3K and
strates a potential mode of Ras-induced conformationalneurofibromin binding (Moodie et al., 1995). Ras Tyr64
changes in PI3Kg.in switch II forms an apparent hydrogen bond to the
side chain of Lys234 and makes hydrophobic contacts
with Phe221 of PI3Kg. These interactions would be lost A Model for Ras Activation of PI3K
The structure of the Ras bound to PI3Kg was used toin the Y64G mutant. Tyr64 also stacks with the carboxyl-
ate of Ras Glu63, which forms a hydrogen bond with construct a model of the activated complex on a lipid
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Table 1. Data Collection, Structure Determination, and Refinement Statistics
Resolution Observations/ Completeness ,I/s.
1Data set (A˚) unique reflections (last shell) (%) Rsym2 (last shell)
Crystal 1 50–3.2 146,371/23,318 100 (100) 0.11 21.8 (3.6)
Crystal 23 50–3.0 270,093/24,791 82.4 (51.3) 0.094 14.7 (1.7)
Merge4 50–3.0 232,825/25,822 91.6 (50.5) 0.10 20.0 (1.7)
Refinement statistics
Resolution Reflections Rfree5 Rmsd from ideality6
Data set (A˚) Protein atoms Waters Work Free Rcryst5 (% data used) Bonds Angles Dihedrals
Merge 50–3.0 7405 6 24,273 1510 0.21 0.28 (5.4) 0.0093 A˚ 1.298 22.78
1 The data from crystals 1 and 2 were collected at ESRF Beamline ID14-1.
2 Rsym 5 ohkloiuIi(hkl) 2 ,l(hkl).u/ohkloiIi(hkl).
3 Only 50 degrees were collected due to radiation damage caused by long exposure.
4 The merged dataset was created by combining the data from crystals 1 and 2 in SCALA.
5 Rcryst and Rfree 5 ouFobs 2 Fcalcu/oFobs; Rfree calculated with the percentage of the data shown in parentheses.
6 Rms deviations for bond angles and lengths in regard to Engh & Huber parameters (Engh and Huber, 1991).
activation studies, the DASAA and DEDAA mutants were subclonedmembrane. When the PI3Kg active site is oriented to-
into pVL1393 with a C-terminal His6 tag.ward the membrane surface and the C2 domain is bind-
PI3K constructs in pVL1393 were transfected into Sf9 cells withing phospholipids, the 20 residue tail of Ras (not present
BaculoGold DNA (Pharmingen). Infected cells were incubated at
in the Ras construct used for crystallization) has ample 278C for 48 hr. Harvested cells were washed in PBS, pelleted, frozen
length to span the gap between the Ras effector domain in liquid nitrogen, and stored at 2808C.
The DNA sequence encoding residues 1–166 of H. sapiens H-Rasand its farnesyl membrane anchor (Figure 6). The loops
G12V was cloned as a NdeI/BamHI fragment into pET11a (Novagen)of the PI3Kg catalytic domain near the putative mem-
and transformed into C41(DE3) cells. For expression, bacteria werebrane interface contain basic residues which could bind
grown at 378C to an OD600 of 0.7, and induced with 100 mM IPTGnegatively charged phospholipid headgroups and hy-
for 12 hr. Full-length, his-tagged H-Ras mutants (a gift from J. Down-
drophobic residues capable of inserting into the mem- ward) were grown in a similar manner and induced for 5 hr with 500
brane to help tether the enzyme in place. mM IPTG.
In the Ras·PI3Kg complex, the C2 and catalytic do-
Protein Purificationmains are slightly spread apart from each other (Figure
P110g proteins were purified using immobilized metal affinity, cation5A), presenting the active site to the membrane. This
exchange, and gel filtration chromatography as previously de-structural change may affect phosphoinositide binding
scribed (Walker et al., 2000). The proteins were gel filtered in a buffer
in the active site, or increase the general affinity of consisting of 20 mM Tris (pH 7.2), 10–50 mM (NH4)2SO4, 1% betaine,
the enzyme for the membrane interface. Although a 1% ethylene glycol, 0.02% CHAPS, and 5 mM DTT, concentrated
substantial component of the Ras activation of PI3Kg to 4–6 mg/mL and snap frozen.
H-Ras 1–166 was extracted from 1 liter of bacterial culture withcould be via translocation to the membrane, an allo-
B-PER reagent (Pierce) and purified by two passages over a HiLoadsteric mechanism, as suggested by the conformational
Q column (Pharmacia) with a salt gradient (0–1 M KCl in 50 mM Trischange, may also be a component of Ras activation.
[pH 7.5], 1 mM MgCl2, 5 mM GDP, and 1 mM DTT). The protein wasThe costimulation of PI3Kg by Gbg and Ras is consis- gel filtered on a Superdex 75 column (Pharmacia) in storage buffer
tent with the emerging view of PI3Ks as integrators of (50 mM Tris [pH 7.5], 1 mM MgCl2, 5 mM GDP, and 1 mM DTT),
multiple signaling pathways. The success of our design concentrated to 20 mg/mL, and snap frozen. Full-length H-Ras mu-
tants were purified as previously described (Rodriguez-Viciana etof both complex-stabilizing and destabilizing mutants,
al., 1997). H-Ras was loaded with GMPPNP using the alkaline phos-in conjunction with the novel interactions observed in
phatase protocol as described previously (Herrmann et al., 1996).the Ras·PI3Kg structure, suggest new possibilities for
Posttranslationally modified H-Ras was obtained by infecting Sf9
the design of PI3K and Ras variants to control specific cells with a baculovirus encoding EE-tagged H-Ras. Cells were har-
signal transduction pathways. vested after 2.5 days and sonicated in a buffer consisting of 5 mM
MgCl2, 100 mM GDP, 1mM DTT, 5 mM EGTA, 0.15 M NaCl, 40 mM
HEPES (pH 7.4) (58C), and protease inhibitors. Modified H-Ras wasExperimental Procedures
separated from unmodified H-Ras by Triton X-114 partitioning and
purified by immunoprecipitation with protein G Sepharose coupledProtein Cloning and Expression
to an anti-EE antibody. Proteins were eluted in a buffer containing 1%For crystallography, equilibrium binding, and kinetic measurements,
sodium cholate, 10 mM GDP, 1 mM DTT, 1mM EGTA, 5 mM MgCl2,a construct containing residues 144–1102 of the human PI3Kg with
and eluting peptide (150 mg/ml) as described in Stephens et al., 1997,a C-terminal His6 tag was cloned into pVL1393 (Invitrogen) for bacu-
concentrated to approximately 2–3 mg/ml, and stored at 2808C.lovirus expression. To make the RBD mutants, we used a cassette
containing a V326A mutation, which encoded a NheI site used for
subcloning. This V326A “pseudo wild-type” construct has the same In Vitro and In Vivo Activity Measurements
H-Ras was loaded with GTPgS or GDP by incubation with a 10-foldaffinity for N-Ras as the wild-type protein (Figure 2A). The DASAA
PI3Kg mutant used for the in vitro and in vivo experiments contains molar excess of the relevant nucleotide in 5 mM EDTA/5 mM MgCl2.
After 20 min at 208C, MgCl2 was added to a final concentration ofthe T232D, K251A, K254S, K255A, and K256A mutations in the con-
text of the full-length pseudo wild-type p110g subunit. The DEDAA 10 mM and the protein was frozen at 2808C.
Pig neutrophil membranes were obtained as described previouslymutant contains the T232D, K251E, K254D, K255A, and K256A muta-
tions. For expression in COS-7 cells, the DASAA and DEDAA mu- (Bennett et al., 1982). Assays were carried out by incubating neutro-
phil membranes (5 mg protein) with GTPgS or GDP-loaded post-tants were subcloned into pcDNA3 with no tags. For in vitro Ras
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translationally modified H-Ras (final concentration in assay, 1 mM, GMPPNP. The data were fitted to the binding equation with Kaleida-
graph.with a final cholate concentration of 0.1%) in a buffer containing
All kinetic data were collected in a Hi-Tech MX61 instrument set0.1 M KCl, 1mM EGTA, 5mM MgCl2, 20mM HEPES (pH 7.5) at 58C,
up in the single push mode with lex 5 280 nm and emission moni-1mM DTT (in a total volume of 6 ml) on ice. After incubation for 10
tored with 399 nm cutoff filters. A solution of PI3K was mixed withmin, 1 ml of PI3K (300 ng) was added; p110g was stored at 2–4 mg/
a solution of mant-ATP such that the final PI3K concentration wasml in 20 mM Tris (pH 7.2), 30mM (NH4)2SO4, 1% betaine, 1% ethylene
1 mM and the ATP concentrations were 2.5, 5, 7.5, 10, 12.5, and 25glycol, 0.02% CHAPS, and 5 mM DTT and diluted z10-fold into PBS
mM. The displacement experiment was carried out by mixing 1 mMcontaining 1mM EDTA and 1mM DTT before addition into the assays.
PI3K and 2 mM mant-ATP with 50 or 200 mM ATP. Curve fits wereAfter an additional 5 min, buffer containing [g-32P]ATP (20 mCi per
carried out with the Hi-Tech software and Kaleidagraph. Equilibriumassay with a final ATP concentration of 200 mM with 1.26 mM MgCl2,
and kinetic data for mant-ADP were collected by the same methods.0.1M KCl, 20 mM HEPES (pH 7.5, 58C), 1mM DTT, and 1mM EDTA)
was added and the reactions were transferred to 308C. After 3 min,
Crystallographythe assays were quenched, and the lipids extracted, deacylated,
H-Ras·GMPPNP and PI3Kg (V223K in the context of the 144–1102analyzed by HPLC, and quantitated as described previously (Ste-
pseudo wild-type construct) were mixed to final concentrations ofphens et al., 1997).
170 mM for H-Ras and 29 mM for PI3K. The mixture was incubatedCOS-7 cells were transfected with plasmid DNA (5–10 mg of full-
for 3 days at 178C, and then set in hanging drops against a reservoirlength PI3Kg, myc-tagged p101, H-Ras G12V, or an unrelated con-
of 50 mM KH2PO4/K2HPO4 (pH 6.3) and 4.3% PEG 8000. Crystalstrol DNA for a total of 15–25 mg per transfection in a final volume
were propagated by hair seeding and grew to dimensions of 120of 0.5 mL) as described previously (Stephens et al., 1997). After
mm 3 70 mm 3 50 mm in 10 days. SDS–PAGE analysis of the crystalselectroporation, the cells were plated in 6 cm diameter dishes and
showed that the PI3Kg had been completely digested into four frag-incubated for 36 hr in complete growth medium (DMEM with 10%
ments (43, 32, 20, and 10 kDa) during the time course of crystalliza-v/v FBS), washed, and then incubated in HEPES-buffered DMEM
tion. The largest crystals were transferred to cryoprotectant (reser-containing 1 mM NaHCO3 and 0.2% (w/v) fatty acid-free BSA (starva-
voir with 40% trehalose) in two brief steps and frozen in a liquid N2tion medium). After 8 hr, the cells were washed with a phosphate-
cryostream.free version of the starvation medium and incubated for 90 min with
Data sets were collected at beamlines ID14–2 and ID14–1 at the0.25–0.5 mCi [32P]-Pi per dish. For cells treated with U0126, the drug
European Synchotron Radiation Facility in Grenoble at a wavelengthwas added to the starvation medium to a final concentration of 10
of 0.934 A˚ (Table 1). The space group was P3121 with cell dimensionsmM, and was continuously present in the wash and labeling solutions
of a 5 113.6 A˚, c 5 183.9 A˚, and one complex in the asymmetricuntil cell harvesting. The cells were harvested and 32P-labeled phos-
unit. The reflections from two crystals were indexed and integratedpholipids measured as described previously (Stephens et al., 1997).
with MOSFLM (Leslie, 1992), merged, and scaled with SCALA (CCP4,
1994). Molecular replacement was carried out with AMoRe. The
initial model consisted of our human PI3Kg structure (Walker et al.,Anisotropy Titrations
2000). A second rotation/translation search with the structure ofMant-nucleotides were synthesized as described previously (Jame-
Ras (Pai et al., 1990) (PDB:5p21) located the Ras molecule. Theson and Eccleston, 1997). N-Ras and H-Ras mutants were loaded
partial model was rebuilt in O (Jones et al., 1991) and refined withwith mant-GMPPNP as in Moore et al., 1993, gel filtered into running
CNS (Brunger et al., 1998). The average B factor is 70 A˚2. No residuesbuffer (20 mM Tris [pH 7.5], 2 mM MgCl2, and 1 mM DTT), and frozen
are in the disallowed regions of the Ramachandran plot. Figuresat 2808 C. The concentration of Ras·mant-GMPPNP was determined
were prepared with MOLSCRIPT (Kraulis, 1991), GRASP (Nichollsby measuring the absorbance of the mant group at 350 nm with e 5
et al., 1991), and Raster3D (Merritt and Bacon, 1997).5700 M21 cm21 (Hiratsuka, 1983). For binding assays, the 144–1102
In the structure, all residues in the Ras are visible. The orderinghuman PI3Kg was titrated into a 1 mM solution of full-length, unmodi-
of the 255–267 loop and better side chain definition at places in thefied N-Ras·mant-GMPPNP. Data were collected with SLM 8000 S
region from 228 to 255 showed that there was a register shift in theand ISS PC1 spectrofluorimeters, set up in the T-format and L-for-
fit of the sequence to the electron density in this region in the originalmat, respectively, with prism polarizers. All measurements were
structure of PI3K.taken at 208C with a lex of 366 nm. The emission PMTs were fitted
As in the previous structure of the free PI3Kg, several loops arewith 399 nm cutoff filters. Five measurements of each data point
not visible in the electron density. These include the RBD-C2 domainwere obtained and averaged. Data were fitted to the binding
linker (residues 323–352), CBR3 in the C2 domain (residues 436–equation.
456), the loop between C2b7 and C2b8 (residues 489–497), the
activation loop in the catalytic domain (residues 969–980), and resi-
Stopped Flow Anisotropy dues1085 to 1102 in the C terminus. Several loops that were defined
in the free PI3K are not visible in the electron density of the complex.A Hi-Tech MX61 instrument (Hi-Tech, Salisbury) set up in the T-for-
These include CBR1 (residues 375–378) and loops between residuesmat with prism polarizers was used to collect data at 208C. The
754–760, residues 896–901, and residues 1038–1046. It is possiblemant group was excited at 366 nm and emission monitored through
that some of the disordered loops not visible in the electron density399 nm cutoff filters. The association kinetics were followed by rapid
also correspond to sites of proteolytic nicking (see above).mixing of PI3Kg with 1 mM N-Ras·mant-GMPPNP under pseudo
The N-terminal half of the helical domain (residues 527–620, con-first-order conditions (PI3Kg in large excess). Specifically, equal
taining helices hA1 to hB29) is not present in the structure. Sincevolumes of N-Ras and PI3Kg were mixed to a final Ras concentration
the Ras of a symmetry-related complex packs in this space, andof 1 mM and final PI3Kg concentrations of 5 and 10 mM. The dissocia-
SDS-PAGE analysis of the crystals showed no full-length PI3Kg,tion rate was measured by mixing a solution of 1 mM N-Ras·mant-
this half of the domain was lost to proteolysis during crystallization.GMPPNP and 5 mM PI3K with 9 mM N-Ras·GMPPNP. Attempts to
determine association rates at higher PI3K concentrations were
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